0
0
0
0
1
2
3
$0
Is Albemarle solid or fragile? The Finex Financial Health Scanner reads ALB's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $5.1B |
|---|---|
| Net income | -$510.6M |
| Operating margin | -7.1% |
| Net margin | -9.9% |
| Cash and investments | $1.6B |
| Total debt | $3.2B |
| Free cash flow | $1.3B |
| Revenue growth (1 year) | -4.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.